Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

Details for Australian Patent Application No. 2006304584 (hide)

Owner Athersys, Inc.

Inventors Bennani, Youssef L.; Porter Huck, Emilie; Campbell, Michael G.; Dastrup, David

Agent Spruson & Ferguson

Pub. Number AU-B-2006304584

PCT Pub. Number WO2007/047775

Priority 60/726,793 14.10.05 US

Filing date 16 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 24 November 2011

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047775 Priority application(s): WO2007/047775

24 November 2011 Application Accepted

  Published as AU-B-2006304584

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304589-System and method for identifying road features

2006304581-Microfluidic cell culture device